Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis

被引：0
作者：
Keiichiro Mori
Florian Janisch
Mehdi Kardoust Parizi
Hadi Mostafaei
Ivan Lysenko
Dmitry V. Enikeev
Shoji Kimura
Shin Egawa
Shahrokh F. Shariat
机构：
[1] Medical University of Vienna,Department of Urology
[2] The Jikei University School of Medicine,Department of Urology
[3] Medical University of Hamburg,Department of Urology
[4] Shariati Hospital,Department of Urology
[5] Tehran University of Medical Sciences,Research Center for Evidence Based Medicine
[6] Tabriz University of Medical Sciences,Department of Urology
[7] Weill Cornell Medical College,Department of Urology
[8] University of Texas Southwestern,Department of Urology, Second Faculty of Medicine
[9] Karl Landsteiner Institute of Urology and Andrology,Institute for Urology and Reproductive Health
[10] Charles University,undefined
[11] I.M. Sechenov First Moscow State Medical University,undefined
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Alkaline phosphatase (ALP); Hormone-sensitive prostate cancer (HSPC); Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：247 / 257
页数：10
相关论文
共 210 条
[1]  
Siegel Rebecca L.(2018)Cancer statistics, 2018 CA: A Cancer Journal for Clinicians 68 7-30
[2]  
Miller Kimberly D.(2015)Chemohormonal therapy in metastatic hormone-sensitive prostate cancer New Engl J Med 373 737-746
[3]  
Jemal Ahmedin(2017)Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer New Engl J Med 377 352-360
[4]  
Sweeney CJ(2014)The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy World J Urol 32 669-676
[5]  
Chen YH(2016)A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel Ann Oncol 27 454-460
[6]  
Carducci M(2014)Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer J Clin Oncol 32 671-677
[7]  
Fizazi K(2010)Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer Clin Cancer Res 16 203-211
[8]  
Tran N(2009)Critical review of prostate cancer predictive tools Fut Oncol (Lond Engl) 5 1555-1584
[9]  
Fein L(2011)Tumor markers in prostate cancer I: blood-based markers Acta Oncol (Stockholm, Sweden) 50 61-75
[10]  
Kluth LA(1997)Prognostic factors among 130 patients with osteosarcoma Clin Orthop Relat Res 345 206-214
12345678910